Ledasorexton (INN; developmental code name E-2086) is a selective orexin OX2 receptor agonist which is under development for the treatment of narcolepsy. It is taken orally.
The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.